Company: PETVW
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023398
Chunk: 60

Company: PetVivo Holdings, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 2
Chunk 60
---
 (“VetStem”) entered into an Exclusive
License and Supply Agreement pursuant to which VetStem will license to us, on an exclusive basis, the right to sell, have sold, offer
for sale and import Therapeutic Compositions and Products involving PrecisePRP™ equine and PrecisePRP™ canine. Exclusivity
shall be maintained as long as the mutually agreed upon annual minimum purchases of Products are made during the first five years of
the Agreement, with an option to extend exclusivity upon the mutual agreement of the Parties.

VetStem,
Inc. is a veterinarian-led company established in 2002 to bring regenerative medicine to the veterinary profession. Based near San Diego,
California, this privately held biopharmaceutical enterprise offers veterinarians a range of regenerative modalities, including autologous
stem cell processing from patients’ own fat tissue. With over 15 years of expertise and thousands of treatments for joint, tendon,
and ligament issues, VetStem has made regenerative medicine a therapeutic reality. The VetStem team is dedicated to developing clinically
practical and affordable solutions that harness the natural restorative abilities of living organisms. In addition to its own patents,
VetStem holds exclusive global veterinary licenses to a significant portfolio of patents in regenerative medicine and is in the late
stages of approval of additional regenerative medicine solutions for the veterinarian.

PrecisePRP™ is
a first-in-class off-the-shelf platelet-rich plasma (PRP) product designed for use by veterinarians. It is a leucoreduced, allogeneic,
pooled, freeze-dried PRP intended to provide a species-specific source of concentrated platelets in plasma for intra-articular administration
in dogs and horses. Unlike any PRP mechanical kits currently on the market. PrecisePRP™ does not require a blood draw or centrifugation
making it a truly off-the-shelf product that is easy and convenient. Perhaps more important is the uniformity and consistency that PrecisePRP™ guarantees.
Each vial of PrecisePRP™ contains a consistent dose of 4 billion platelets per vial at a concentration of 500,000
platelets per microliter and is leucoreduced with less than 1,500 white blood cells per microliter.

To
significantly minimize safety risks, all dog and horse donors are screened according to the FDA CVM Guidance 254. Along